01:05 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target price by USD1 to USD45 and change our primary valuation methodology to P/E from P/B, as we think the market's focus is rightly moving from balance sheet risk to the group's normalized earnings power. Our target price is derived by applying a forward P/E multiple of 14.5x to our 2026 EPS forecast, representing a premium to UBS's five-year historical average of 13.3x, which we believe is warranted given the fundamentally improved profile of the post-acquisition group. We maintain our Buy rating as UBS's exceptional Q3 results validate the power of its diversified franchise. The accelerated, ahead-of-schedule CS integration de-risks the investment case and provides a clearer path to achieving superior returns, reinforcing our confidence in future shareholder value creation. We raise our EPS forecasts to USD2.15 (from USD1.90) for 2025 and to USD3.10 (from USD2.90) for 2026, bringing our estimates more in line with consensus.